Xenothera

French tech company | Builders Republic

About

Biotech developing immunological therapies based on a proprietary glyco-humanized polyclonal antibody platform — with programs in oncology (peripheral T-cell lymphoma, LIS22 antibody) and xenotransplantation, in partnership with INSERM, Institut Pasteur and Brigham Health.

Key facts

Status
Active
Sectors
Healthcare & Life Sciences
Latest stage
Venture Round
Founded
2014
City
NANTES
Region
Pays de la Loire
Tracked rounds
1
Amount raised
20 M€ raised since 2020

Funding rounds

  • Venture Round — 2021

Investors